HIMS (Hims & Hers Health) LT-Debt-to-Total-Asset: 0.50 (As of Mar. 2026)

What is Hims & Hers Health LT-Debt-to-Total-Asset?

Hims & Hers Health HIMS -2.64% 81 LT-Debt-to-Total-Asset is 0.50 as of Mar. 2026. GuruFocus rates HIMS with a GF Score™ of 81/100 and a GF Value™ of $38.70 (Modestly Undervalued). The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Hims & Hers Health's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.50.

Hims & Hers Health's long-term debt to total assets ratio increased from Mar. 2025 (0.07) to Mar. 2026 (0.50). It may suggest that Hims & Hers Health is progressively becoming more dependent on debt to grow their business.

Hims & Hers Health (NYSE:HIMS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Hims & Hers Health LT-Debt-to-Total-Asset Related Terms

Hims & Hers Health LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health LT-Debt-to-Total-Asset Chart

Hims & Hers Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.02

0.01

0.52

Hims & Hers Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.07	0.56	0.50	0.52	0.50

81GF Score

Hims & Hers Health Inc HIMS

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Hims & Hers Health LT-Debt-to-Total-Asset Calculation

Hims & Hers Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	1115.747	/	2154.705
	=	0.52

Hims & Hers Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	1126.458	/	2267.043
	=	0.50

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.50 mean?

Hims & Hers Health (HIMS) has a LT-Debt-to-Total-Asset of 0.50 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Hims & Hers Health and its competitors.

Is Hims & Hers Health's LT-Debt-to-Total-Asset too high?

Hims & Hers Health's current LT-Debt-to-Total-Asset is 0.50. Overall, Hims & Hers Health has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Hims & Hers Health's LT-Debt-to-Total-Asset compare to LNTH and LQDA?

Hims & Hers Health's LT-Debt-to-Total-Asset of 0.50 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?

A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current LT-Debt-to-Total-Asset is 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Hims & Hers Health stock overvalued right now?

Based on GuruFocus' analysis, Hims & Hers Health (HIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is $38.70, compared to a current price of $32.51 — trading 16% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.50. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Hims & Hers Health (HIMS), the current LT-Debt-to-Total-Asset is 0.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of $32.51 is trading 16% below its estimated GF Value™ of $38.70. GuruFocus considers Hims & Hers Health to be Modestly Undervalued.

Key valuation signals for HIMS:

LT-Debt-to-Total-Asset: 0.50
GF Value™: $38.70 vs. price of $32.51 (16% below fair value)
GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies LNTH LQDA ALKS AMRX INDV KNSA ELAN RGC SUPN BCRX XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges HIMS:Mexico 82W:Germany

Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123

Website https://www.forhims.com

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

81GF Score

Get the complete analysis for HIMS

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$32.51

Price

$38.70

GF Value

View HIMS Analysis

See LT-Debt-to-Total-Asset data for all stocks →